- Home
- / Johns Hopkins Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Johns Hopkins Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$5.8 M
Revenue
$7.8 B
FY, 2021
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 6.8B | 7.1B | 7.8B |
| General and administrative expense | 2.5B | 2.6B | 2.6B |
| Operating expense total | 6.7B | 7.2B | 7.5B |
| Depreciation and amortization | 291.5M | 310.7M | 311.5M |
| EBIT | 81.2M | (45.7M) | 350.4M |
| EBIT margin, % | 1.2% | -0.6% | 4.5% |
| Investment income | 196.1M | 101.0M | 774.8M |
| Interest expense | 16.2M | 19.7M | 25.1M |
| Net Income | 100.7M | (182.2M) | 1.1B |